March 26-28, 2019 | Boston, MA
Register by Friday, March 22 to secure the best rate!





Lead Partner

We want to be your partner and drive pioneering therapies to the market. We invest in enabling technologies and build expertise to support the development and commercialization of your new innovative therapy. Our scientists and engineers bring decade-long development experience across a broad spectrum of cell types and technologies. This builds the backbone of an extensive service offering, providing you with tailored process and analytical development, manufacturing and regulatory services. Visit our website to find out how we can develop the next milestone in cell and gene therapy together:


Project Farma

Program Partner

Project Farma is an industry leader in providing project management, validation, engineering and consulting services with a proven track record in gene and cell therapy. We partner with cell and gene therapy organizations in addition to healthcare, pharmaceutical, bio-pharmaceutical companies to support finding ground-breaking treatments and solutions. Our clients include startups, small and large pharmaceutical and biotech companies and CMOs/CROs. We are committed to helping advance cutting-edge medicines by leveraging our deep knowledge and broad experience in cell and gene therapy to meet any new challenges.  With over 200 employees, our business infrastructure enables robust scalability to ensure that the proper resources are available to support the project.


Expertise Partner

Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®.  Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions.

BIA Separations

Program Partner

BIA Separations has 20 years’ experience in chromatographic purification. Our products, CIM monoliths,  were designed with unique operating properties that make them ideally suited to the challenging requirements of purifying biomolecules such as virus particles, vesicles, proteins, RNA’s, plasmids and other forms of DNA. We provide products that range from small analytical columns to large industrial prep-scale columns (including cGMP and disposable units) as well as method development services.

Brammer Bio

Program Partner

Brammer Bio is dedicated to providing clinical and commercial viral vectors for in vivo gene and ex vivo gene-modified cell therapies, from process and analytical development through commercial approval. We have a highly skilled team of scientists with expertise from over 100 client projects to tackle the challenges posed by these novel technologies and help accelerate their transition from the clinic to patients, while focusing on meeting cGMP standards. Brammer Bio is Helping to Cure.®

Trinity Partners 

Program Partner

Trinity Partners is a global life sciences strategy consulting company. We partner with leading pharmaceutical, biotech, and medical device / diagnostic companies to provide best-in-class strategic support and evidence-based insights. Our support spans the lifecycle of development from early stage pipeline assets to life cycle management across a diverse type of business questions. Trinity’s experience touches all types of markets, with orphan/rare diseases being one of our top markets of focus. Our expertise in gene and cell therapy is driven by our commercial understanding of the markets and our scientific background, coupled with deep experience supporting many clients at the forefront of these therapies.


Program Partner

Invitae is bringing comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. As one of the fastest growing genetic information companies, Invitae is advancing the broad potential of genetics. The company provides geneticinformation services for all stages of life – from preconception screening, to newborn diagnosis, to inherited disease screening, to proactive health management – and a unique, rapidly expanding network of patients, hospital systems, and advocacy partners that is moving genetics from onedimensional testing to complex information management.

Paragon Bioservices


Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic proteins, and other complex biologics.




QPS is a global, science driven, customer-focused CRO that provides preclinical studies and clinical trials to the biotech and pharmaceutical industries. Our 1100+ person organization has expertise in nearly all drug modalities including small molecules, proteins, and other biotherapeutics. We have supported gene therapy since 2002:  ASOs, siRNAs, miRNA through mRNAs and viral vectors. Our bioanalytical technologies include LC-HRMS, hybridization-LC, and qPCR; while our full spectrum DMPK services covers PK, DDI, biodistribution, and radiolabel studies.

Precision For Medicine 


Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology, focusing predominantly on genomics, immune-response assays, global specimen logistics, biomarker analytics, companion diagnostics, and clinical trial execution. Precision for Medicine is part of Precision Medicine Group, with more than 1,450 employees in 25 locations in the US, Canada, and Europe.



Rho, a contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 30 years, Rho has been a trusted partner to  leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence,  innovative technologies, and  therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.



Patients First – it’s in our DNA. At CareMetx, we fight for every patient “from intake to outcomes” by providing Hub/reimbursement services, leading-class technology and strategic consulting to accelerate access to life-saving treatments. Speed and efficiency – is why we’re different. CareMetx leverages our expertise and innovative patient eAccess technology to revolutionize the patient experience. We partner with our clients to launch or transition pharmaceutical programs in record time with significant cost savings.

Delphi Genetics


Delphi Genetics is a private biotech company, with proven track record in genetic engineering and bioproduction. The company provides one-stop-shop service from development to GMP manufacturing of plasmid DNA starting material, including DNA for AAV, Lentiviruses, mRNA, as well as DNA API; in its GMP certified facility. Delphi Genetics has developed an innovative antibiotic-free technology (Staby®) for bioproduction. This technology drives better plasmid DNA stabilization, and has been non-exclusively licensed to several big pharmaceutical companies.



Accredo, the first pharmacy to dispense gene replacement therapy in the U.S.,  is a full-service specialty pharmacy dedicated to the treatment of rare and complex conditions. Our comprehensive therapy management programs engage trained pharmacists, nurses, reimbursement specialists, and patient care representatives who provide enhanced support services to patients, their families and healthcare professionals.

Beacon Hill Pharma


Beacon Hill Pharma, Beacon Hill’s Life Sciences specialty division, partners with Gene Therapy, Pharmaceutical, Biotech, Medical Device, Diagnostics, Clinical Research Outsourcing, and other corporations delivering the most qualified Life Sciences resourcing solutions in the market today.  Committed to identifying and delivering qualified candidates that fit your objectives and company culture, we place Life Sciences contractors in all 50 states, seamlessly coordinating recruiting resources in local and regional markets with Beacon Hill Pharma’s National Recruiting & Delivery. 

Vigene Biosciences


Vigene Biosciences’ mission is to Make Gene Therapy Affordable.  Headquartered in Rockville, MD,  Vigene offers FDA and EMA compliant cGMP production for AAV, lentivirus, adenovirus. With a proven record of cGMP grade AAV, lentivirus and adenovirus production, Vigene is combining the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical material clients.   Globally Vigene is proud to serve over 1000 academic, biotech and pharmaceutical labs.

TCTC Group


TCTC GroupTM is a privately owned, full-service clinical research provider specialized in bringing products with unique clinical, medical and regulatory complexities to market. In addition to offering full-service clinical trial solutions, the group includes independent divisions specialized in quality assurance, medical writing and regulatory affairs, project and site management, staffing, data management and training services. Formed in 2002, TCTC GroupTM has a worldwide presence with offices in the UK, Europe, North America, Asia and Australia.


Gene Therapy Center Austria (GTCA)


Gene Therapy Center Austria (GTCA), now part of Takeda, is your innovative partner for high-quality AAV solutions bringing your gene therapy product into phase III and to the market. GTCA is a one-stop-shop covering all steps from vector to product. Our well-established, suspension-based Gene Therapy platform allows vector optimization, process development and GMP manufacturing of your product. Our proprietary platform process is applicable to all AAVs and commercial-ready.


Polyplus Transfection


Polyplus-transfection applies its 15+ year expertise to the development of novel transfection solutions up to GMP grade for high yield transient protein and antibody production in CHO and HEK-293 cells, as well as for viral vector production for Gene and Cell Therapy (PEIpro product range).




We specialize in providing the following services within Clinical Development:

  • Clinical Development Services – (Study Start Up, Phase 1 – Phase 3 Trial support, PM oversight, TMF expertise, Monitoring teams, Protocol planning, Operations)
  • Data Management, Biostatistics, and Programming
  • Regulatory Strategy and Writing
  • Medical Monitoring and Writing
  • Clinical Data Disclosure and Transparency – Expertise in new Global Disclosure Mandates and Lay Summary initiative of 2020

ACF Bioservices Services


ACF Bioservices is a division of Absorption Systems providing analytical support for cell and gene therapy products through every stage of development. Potency assays are on the critical path and ACF offers de novo development, optimization, qualification, validation and GMP compliant final product and product release testing services for both allogenic and autologous therapies. We have the capability to develop both in vitro and in vivo models to better predict human outcomes and correlations between animal studies and in vitro cell-based assays. Our facilities are FDA inspected, AAALAC Accredited, USDA Registered and MRHA Certified.


Diamond Pharma Services

Event Partner

Diamond Pharma Services is a leading European technical and scientific consulting group with deep expertise in gene therapies.  Diamond are proud to have supported the regulatory approval of the first gene therapy product in Europe (Glybera), and continue to work on a broad portfolio of gene, and gene modified cell therapies. Our specialised team has broad and varied industry experience offering both breadth and depth of expertise, from which our clients can benefit.


PPD® Biotech

Event Partner

PPD® Biotech is devoted to finding the right Phase I-IV clinical development solutions for biotech and small to midsize pharma. With dedicated teams, PPD Biotech combines the global resource scalability and full-service offerings of PPD with personal attention, flexibility and a shared mindset that enables us to find the optimal solutions for your study, no matter the size. We bring a comprehensive set of expertise to gene therapy research – from product development and regulatory strategists, labs services and clinical execution through to peri- and post-approval work. We have the right science, trial designs and experienced operations teams to move your gene therapy studies forward.